- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/12 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 471/12
Total number of patents in this class: 187
10-year publication summary
|
19
|
8
|
5
|
10
|
9
|
16
|
12
|
14
|
19
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3168 |
6 |
| LG Chem, Ltd. | 17921 |
4 |
| Merck Patent GmbH | 5728 |
4 |
| ChemoCentryx, Inc. | 361 |
4 |
| Intra-Cellular Therapies, Inc. | 436 |
4 |
| Senhwa Biosciences, Inc. | 36 |
4 |
| Insilico Medicine IP Limited | 169 |
4 |
| BASF SE | 21303 |
3 |
| Takeda Pharmaceutical Company Limited | 2712 |
3 |
| Gilead Sciences, Inc. | 2222 |
3 |
| Owens Corning Intellectual Capital, LLC | 1725 |
3 |
| Suven Life Sciences Limited | 138 |
3 |
| Tel Hashomer Medical Research Infrastructure and Services Ltd. | 328 |
3 |
| Neuron23, Inc. | 28 |
3 |
| Merck Sharp & Dohme LLC | 3734 |
3 |
| Acerand Therapeutics (Hong Kong) Limited | 13 |
3 |
| Novartis AG | 10262 |
2 |
| Bristol-myers Squibb Company | 4742 |
2 |
| Syngenta Crop Protection AG | 6701 |
2 |
| Abbvie Inc. | 1836 |
2 |
| Other owners | 122 |